Diabetes and Obesity Technologies

Unmet Needs in Delivery Systems

Less frequent delivery of medications which provide continuous exposure of medication

Formulation and device systems which are amenable to combination products

Effective and efficient oral delivery systems for biologics in Type 2 diabetes

Glucose-responsive delivery systems for insulin

Desired Product Profile:

Monthly, Quarterly, and Yearly administration providing continuous exposure of GLP-1 and other Type 2 diabetes drugs

Administration by a simple injection in the doctor’s office using a 27 guage needle and less than 1 ml injection volume

Insulin injection that is once per day or once per week and acts as a subcutaneous reservoir delivering insulin based on the glucose level

Patient administered product using a 29 to 31 guage needle and less than 0.5 ml injection volume